Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that data on its lead antibacterial ...
Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced that new clinical data will be presented in two oral ...
The year 2026 marks 30 years since genetically modified organisms (GMO) entered commercial cultivation worldwide. Korea does not allow the cultivation of GMO crops. However, as imported grains such as ...
The AHA Jan. 26 urged the Health Resources and Services Administration to take immediate action to stop a new Eli Lilly and ...
The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all ...
Eli Lilly and Company (NYSE:LLY) is one of the best stocks to buy and hold for 20 years. On January 20, 2026, Guggenheim reduced its price target on Eli Lilly and Company (NYSE:LLY) from $1,163 to $1, ...
3don MSN
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare ...
GLP-1 giant Eli Lilly has once again taken to the medium of short film to deliver an important message about obesity. | GLP-1 ...
Eli Lilly expand 340B reporting requirements to include all covered entities submitting claims-level data by Feb. 1, 2026, with some state exemptions.
12hon MSN
Evangeline Lilly shares treatment plan after traumatic brain injury: ‘I have spent a lot of money’
In May 2025, the "Hobbit" actress showed off the gruesome injuries she sustained after fainting on a rocky beach.
Novo Nordisk developed There’s Only One Ozempic in partnership with Rogue Producer, an independent advertising and content ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results